Back
abrdn Life Sciences Investors 10K Form
Sell
36
HQL
abrdn Life Sciences Investors
Last Price:
$13.47
Seasonality Move:
4.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive HQL News And Ratings
See the #1 stock for the next 7 days that we like better than HQL
HQL Financial Statistics
Sales & Book Value
| Annual Sales: | $124.1M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
abrdn Life Sciences Investors Earnings Forecast
Key abrdn Life Sciences Investors Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 1 years.
abrdn Life Sciences Investors Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Current Symbol: | HQL |
| CUSIP: | 87911K |
| Website: | abrdnhql.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
HQL Technical Analysis vs Fundamental Analysis
Sell
36
abrdn Life Sciences Investors (HQL)
is a Sell
Is abrdn Life Sciences Investors a Buy or a Sell?
-
abrdn Life Sciences Investors stock is rated a SellThe current abrdn Life Sciences Investors [HQL] share price is $13.50. The Score for HQL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.